4.7 Article

Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 24, 页码 16155-16172

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c01633

关键词

-

资金

  1. National Research Foundation (NRF) of Korea - MSIT [NRF-2018R1A5A2025286, 2022M3E5F3080873, 2019R1A2C2004142]
  2. NRF - MSIT [2019R1A2C2086618, 2018R1A5A1024340, 2022M3E5F2017408]
  3. National Research Foundation of Korea [2022M3E5F2017408, 2019R1A2C2086618, 2019R1A2C2004142, 2022M3E5F3080873] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial molecular chaperone that modulates cellular metabolism and signaling pathways. It can alter the conformation, activity, and stability of various substrate proteins. TRAP1 has been proposed as a promising target for anticancer drug development, but dysregulation of its stress-adaptive machinery may contribute to the progression and maintenance of human diseases.
Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial molecular chaperone modulating cellular metabolism and signaling pathways by altering the conformation, activity, and stability of numerous substrate proteins called clients. It exerts its chaperone function as an adaptive response to counter cellular stresses instead of maintaining housekeeping protein homeostasis. However, the stress-adaptive machinery becomes dysregulated to support the progression and maintenance of human diseases, such as cancers; therefore, TRAP1 has been proposed as a promising target protein for anticancer drug development. In this review, by collating recent reports on high-resolution TRAP1 structures and structure-activity relationships of inhibitors, we aimed to provide better insights into the chaperoning mechanism of the emerging drug target and to suggest an efficient strategy for the development of potent TRAP1 inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据